Literature DB >> 8622301

Reexploration for bleeding is a risk factor for adverse outcomes after cardiac operations.

M J Moulton1, L L Creswell, M E Mackey, J L Cox, M Rosenbloom.   

Abstract

OBJECTIVE: Although previous studies have included early reexploration for bleeding as a risk factor in analyzing adverse outcomes after cardiac operations, reexploration for bleeding has not been systematically examined as a multivariate risk factor for increased morbidity and mortality after cardiac surgery. Furthermore, multivariate predictors of the need for reexploration have not been identified. Accordingly, we performed a retrospective analysis of 6100 patients requiring cardiopulmonary bypass from January 1, 1986, to December 31, 1993.
METHODS: Eighty-five patients who had ventricular assist devices were excluded from further analysis because of the prevalence of bleeding and the significant morbidity and mortality associated with placement of a ventricular assist device, unrelated to reexploration. In the remaining 6015 patients, potential adverse outcomes analyzed included operative mortality, mediastinitis, stroke, renal failure, adult respiratory distress syndrome, prolonged mechanical ventilation, sepsis, atrial arrhythmias, and ventricular arrhythmias. To control for the confounding effects of other risk factors, we performed a multivariate logistic regression analysis. Potential covariates considered in the logistic model included age, sex, race, history of reoperation, urgency of the operation, congestive heart failure, prior myocardial infarction, renal failure, diabetes, hypertension, chronic obstructive pulmonary disease or stroke, and the bypass and crossclamp time.
RESULTS: The overall incidence of reexploration was 4.2% (253/6015). Four independent risk factors--increased patient age (p < 0.001), preoperative renal insufficiency (p = 0.02), operation other than coronary bypass (p < 0.001), and prolonged bypass time (p = 0.0.3)--were identified as predictors of the need for reexploration. The preoperative use of aspirin, heparin, or thrombolytic agents and the bleeding time were not identified as predictors. Reexploration for bleeding was identified as a strong independent risk factor for operative mortality (p = 0.005), renal failure (p < 0.0001), prolonged mechanical ventilation (p < 0.0001), adult respiratory distress syndrome (p = 0.03), sepsis (p < 0.0001), and atrial arrhythmias (p = 0.006).
CONCLUSION: These data indicate that meticulous attention to surgical hemostasis and possibly application of recently developed modalities designed to facilitate perioperative correction of coagulopathy could improve outcomes after cardiac operations.

Entities:  

Mesh:

Year:  1996        PMID: 8622301     DOI: 10.1016/s0022-5223(96)70380-x

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  48 in total

1.  Combined coronary artery and abdominal aortic surgery without cardiopulmonary bypass.

Authors:  R Ascione; G Iannelli; N Spampinato
Journal:  Tex Heart Inst J       Date:  2000

2.  Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Michael K Gould; David A Garcia; Sherry M Wren; Paul J Karanicolas; Juan I Arcelus; John A Heit; Charles M Samama
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

3.  An innovative simple technique of blood conservation in adult patients with tetralogy of Fallot and severely raised hemoglobin.

Authors:  Praveen Kumar Neema; Sethuraman Manikandan; Ramesh Chandra Rathod
Journal:  J Extra Corpor Technol       Date:  2007-12

Review 4.  Is there still a role for aprotinin in cardiac surgery?

Authors:  Neel R Sodha; Munir Boodhwani; Frank W Sellke
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

5.  Economies of scale: body mass index and costs of cardiac surgery in Ontario, Canada.

Authors:  Ana P Johnson; Joel L Parlow; Brian Milne; Marlo Whitehead; Jianfeng Xu; Susan Rohland; Joelle B Thorpe
Journal:  Eur J Health Econ       Date:  2016-05-11

6.  Reoperation for bleeding in cardiac surgery.

Authors:  Katrine Lawaetz Kristensen; Line Juul Rauer; Poul Erik Mortensen; Bo Juel Kjeldsen
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-02-24

7.  Recombinant activated factor VII in paediatric cardiac surgery.

Authors:  Jonathan R Egan; Ahti Lammi; David N Schell; Jonathan Gillis; Graham R Nunn
Journal:  Intensive Care Med       Date:  2003-12-19       Impact factor: 17.440

8.  Thromboelastometry guided fibrinogen replacement therapy in cardiac surgery: a retrospective observational study.

Authors:  Francesco Vasques; Luca Spiezia; Alberto Manfrini; Vincenzo Tarzia; Dario Fichera; Paolo Simioni; Gino Gerosa; Carlo Ori; Guido Di Gregorio
Journal:  J Anesth       Date:  2016-10-18       Impact factor: 2.078

9.  Dual antiplatelet therapy in patients requiring urgent coronary artery bypass grafting surgery: a position statement of the Canadian Cardiovascular Society.

Authors:  David Fitchett; John Eikelboom; Stephen Fremes; David Mazer; Steve Singh; Bindu Bittira; Stephanie Brister; John J Graham; Milan Gupta; Keyvan Karkouti; Agnes Lee; Michael Love; Rod McArthur; Mark Peterson; Subodh Verma; Terrence M Yau
Journal:  Can J Cardiol       Date:  2009-12       Impact factor: 5.223

Review 10.  Coagulation disorders of cardiopulmonary bypass: a review.

Authors:  Domenico Paparella; Stephanie J Brister; Michael R Buchanan
Journal:  Intensive Care Med       Date:  2004-07-24       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.